Neurodevelopmental Disorders: Clinical Trials

45 trials for Neurodevelopmental Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 unknown. 45 Phase 2, 9 Phase 1, 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 245Unknown 45
Phase 19Unknown 9
Phase 38Unknown 8

Follow Neurodevelopmental Disorders: new trials by email Literature Review of Neurodevelopmental Disorders trials Research Report on Neurodevelopmental Disorders

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Black Seed Oil in ADHD
Atomoxetine, Black Seed Oil Cap/Tab - ADHD
Phase 2UnknownAin Shams University602024-10-012024-08-09
Intranasal Oxytocin in Youth With Autism
Oxytocin nasal spray, Placebo - Autism Spectrum Disorder
Phase 2UnknownOslo University Hospital1282024-09-182024-06-24
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Oral CBD oil enriched with terpenes, Oral Placebo - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2UnknownBazelet Nehushtan LtD.1202024-08-222024-08-23
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
MTP-101P, Vancomycin, Miralax - Autism Spectrum Disorder, Gastro-Intestinal Disorder
Phase 2UnknownGut-Brain-Axis Therapeutics Inc.602024-08-202024-09-25
Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD
Modified Atkin's Diet with standard of care, Standard of Care - Modified Atkins Diet, Autism Spectrum Disorder
Phase 2 / Phase 3UnknownAll India Institute of Medical Sciences802024-03-202024-03-18
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD
Behavior therapy, Psychoeducation - Autism Spectrum Disorder
Phase 2 / Phase 3UnknownStanford University902024-01-052024-08-27
Home-based Transcranial Direct Current Stimulation (tDCS) to Promote Social Communication and Behaviour in Children With Autism Spectrum Disorder (ASD)
At-home transcranial direct current stimulation (tDCS), Sham at-home tDCS - Autism Spectrum Disorder
Phase 2UnknownHolland Bloorview Kids Rehabilitation Hospital202023-10-202024-07-30
Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
repetitive transcranial magnetic stimulation (rTMS), Sham stimulation - Autism Spectrum Disorder, Self-Regulation, Emotion
Phase 2UnknownHolland Bloorview Kids Rehabilitation Hospital502022-09-222024-07-26
CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
Oral cannabidiol 100mg/mL, Placebo - Autism Spectrum Disorder
Phase 2UnknownUniversity of Colorado, Denver862021-12-152024-05-08
Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
Treadmill workstation, Methylphenidate - Attention Deficit Disorder
Phase 2 / Phase 3UnknownAriel University302021-10-012022-03-31
Adjunctive Celecoxib in Childhood-onset OCD Study
Celecoxib, Placebo - Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder
Phase 2UnknownUniversity of British Columbia802021-06-012022-12-16
Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
Clozapine, haloperidol, pimozide, olanzapine, risperidone, amisulpride - Psychosis, Intellectual Disability
Phase 2UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla752020-11-262024-03-20
Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study
Autologous umbilical cord blood, Placebo - Autistic Spectrum Disorder
Phase 2UnknownSheba Medical Center602020-02-272021-01-20
Acute Effects of Stimulant Medication in College Students With ADHD
Adderall IR 10mg, Placebo - Attention Deficit Hyperactivity Disorder, Stimulant Use
Phase 2UnknownUniversity of Wyoming402020-02-112024-06-10
The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial
Cognitive Traning with The Secret Trail of Moon, Cognitive Traning with Therapeutic Chess, Control Group - Attention Deficit Disorder With Hyperactivity
Phase 2UnknownPuerta de Hierro University Hospital1052019-12-092020-04-21
Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility.
ASD CB-MNC infusion low level HLA compatibility., ASD CB-MNC infusion high level HLA compatibility., Standard therapy. - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2UnknownState-Financed Health Facility "Samara Regional Medical Center Dinasty"1502019-08-102023-01-18
Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
Magnesium and Vitamin B6 - Autism Spectrum Disorder
Phase 2UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh502019-01-012019-07-31
Outcomes Mandate National Integration With Cannabis as Medicine
Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome
Phase 2UnknownOMNI Medical Services, LLC2000002018-12-012022-06-02
A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome
THX-110 (dronabinol plus PEA), Placebo - Tourette Syndrome
Phase 2UnknownNeurothera Labs Inc.602018-08-012018-08-29
Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective
Potassium Gluconate Oral Capsule, Placebo oral capsule - ADHD
Phase 1 / Phase 2UnknownAlkaliDx, Inc.1002018-07-012018-06-20

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Attention Deficit Disorder with Hyperactivity (18)  ·  Autism Spectrum Disorder (12)  ·  Autistic Disorder (8)  ·  Child Development Disorders, Pervasive (3)  ·  Depression (3)  ·  Intellectual Disability (3)  ·  Anxiety Disorders (2)  ·  Communication Disorders (2)  ·  Constipation (2)  ·  Diarrhea (2)  ·  Dyslexia (2)  ·  Tourette Syndrome (2)  ·  Abdominal Pain (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Amyotrophic Lateral Sclerosis (1)

Broader conditions

Mental Disorders (45)  ·  Attention Deficit and Disruptive Behavior Disorders (18)  ·  Child Development Disorders, Pervasive (16)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Nervous System Diseases (10)  ·  Signs and Symptoms (10)  ·  Neurologic Manifestations (9)  ·  Neurobehavioral Manifestations (7)  ·  Autism Spectrum Disorder (6)  ·  Behavior (5)  ·  Behavioral Symptoms (3)  ·  Chemically-Induced Disorders (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)

Interventions

Methylphenidate (3)  ·  Standard of Care (2)  ·  Therapeutics (2)  ·  Transcranial Magnetic Stimulation (2)  ·  Amantadine (1)  ·  Amisulpride (1)  ·  Antacids (1)  ·  Atomoxetine Hydrochloride (1)  ·  Behavior Therapy (1)  ·  Cannabidiol (1)  ·  Celecoxib (1)  ·  Clozapine (1)  ·  Cognitive Remediation (1)  ·  Control Groups (1)  ·  Dronabinol (1)

Sponsors

Chaitanya Hospital, Pune (2)  ·  Holland Bloorview Kids Rehabilitation Hospital (2)  ·  Tehran University of Medical Sciences (2)  ·  University of British Columbia (2)  ·  Ain Shams University (1)  ·  AlkaliDx, Inc. (1)  ·  All India Institute of Medical Sciences (1)  ·  Ariel University (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Bazelet Nehushtan LtD. (1)  ·  Braingear Technologies GmbH (1)  ·  Central Hospital, Nancy, France (1)  ·  Chang Gung Memorial Hospital (1)  ·  Erasmus Medical Center (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)

Countries

United States (11)  ·  Canada (6)  ·  Israel (5)  ·  Germany (3)  ·  Spain (3)  ·  Brazil (2)  ·  France (2)  ·  India (2)  ·  Iran (2)  ·  Japan (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Russia (1)

Top investigators

Shahin Akhondzadeh, Ph.D. (2)  ·  Adele Diamond, Ph.D. (1)  ·  Anil Chacko, PhD (1)  ·  Benedicto Crespo Facorro, Professor (1)  ·  Bruno Leheup, M.D, Ph.D (1)  ·  Clara Westwell-Roper, MD, PhD (1)  ·  Cynthia M Hartung, Ph.D. (1)  ·  David S Wilensky, MD (1)  ·  Debora Arnaut, PSYD (1)  ·  Deryk Beal, PhD (1)  ·  Diane Purper-Ouakil, MD/PhD (1)  ·  Dr. Ryan O Lakin, MD JD (1)  ·  Faye Mishna, PhD (1)

Results publications

PMID 10917410, PMID 12849360, PMID 15026214, PMID 15212606, PMID 15328899, PMID 19148734, PMID 20075648, PMID 24117656, PMID 24434529, PMID 25436448, PMID 25505396, PMID 25911280, PMID 26325247, PMID 27558893, PMID 28149281, PMID 29234356, PMID 30659782, PMID 31217257, PMID 31370811, PMID 31677152, PMID 32731812, PMID 32781397, PMID 34165190, PMID 34370610, PMID 34468332, PMID 35067719, PMID 35105633, PMID 36061275, PMID 36548042, PMID 37093628, PMID 37385583, PMID 37811711, PMID 38461957, PMID 38807685, PMID 40301914, PMID 41103807, PMID 42190642, PMID 9000892

NIH funding

2015 (1), 2019 (1), R01MH061563 (1)